Alginate Hydrogel Formulation with Ketorolac for the Treatment of Pain Related Sialolithiasis

Abstract: Sialolithiasis mainly affects the oral salivary glands due to the presence of small stones that obstruct the secretion of saliva. The treatment and control of pain and inflammation during the course of this pathology is essential to guarantee the patient's comfort. For this reason, a ketor...

Descripción completa

Detalles Bibliográficos
Autores: Silva, Cristina; Ramos Yacasi, Gladys Rosario; Mallandrich Miret, Mireia; Colom Codina, Helena; Suñer Carbó, J. (Joaquim); Noelia Pérez-González; Calpena Campmany, Ana Cristina; Fernández Campos, Francisco
Tipo de documento: Artículo
Estado:Published version
Fecha de publicación:2023
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/200227
Acceso en línea:https://hdl.handle.net/2445/200227
Nivel de acceso:Acceso abierto
Palabra clave:Glàndules salivals
Gels (Farmàcia)
Desenvolupament de medicaments
Salivary glands
Gels (Pharmacy)
Drug development
_version_ 1878738443985485824
author Silva, Cristina
author2 Ramos Yacasi, Gladys Rosario
Mallandrich Miret, Mireia
Colom Codina, Helena
Suñer Carbó, J. (Joaquim)
Noelia Pérez-González
Calpena Campmany, Ana Cristina
Fernández Campos, Francisco
author2_role author
author
author
author
author
author
author
author_browse Calpena Campmany, Ana Cristina
Colom Codina, Helena
Fernández Campos, Francisco
Mallandrich Miret, Mireia
Noelia Pérez-González
Ramos Yacasi, Gladys Rosario
Silva, Cristina
Suñer Carbó, J. (Joaquim)
author_facet Silva, Cristina
Ramos Yacasi, Gladys Rosario
Mallandrich Miret, Mireia
Colom Codina, Helena
Suñer Carbó, J. (Joaquim)
Noelia Pérez-González
Calpena Campmany, Ana Cristina
Fernández Campos, Francisco
author_role author
collection Dipòsit Digital de la UB
description Abstract: Sialolithiasis mainly affects the oral salivary glands due to the presence of small stones that obstruct the secretion of saliva. The treatment and control of pain and inflammation during the course of this pathology is essential to guarantee the patient's comfort. For this reason, a ketorolac calcium cross-linked alginate hydrogel was developed, and it was then applied in the area of the buccal cavity. The formulation was characterized (swelling and degradation profile, extrusion, extensibility, surface morphology, viscosity, and drug release). The drug release was studied ex vivo in static Franz cells and with a dynamic ex vivo method under artificial saliva continuous flow. The product exhibits adequate physicochemical properties considering the intended purpose, and the drug concentrations retained in the mucosa were high enough to deliver a therapeutic local concentration able to reduce the pain associated with the patient's conditions. The results confirmed the suitability of the formulation for application in the mouth.
eu_rights_str_mv openAccess
format article
id ES_af190d2fe09dd9ca9f231c78b28d43f9
institution Universidad de Barcelona
instname_str Universidad de Barcelona
network_acronym_str ES
network_name_str España
oai_identifier_str oai:diposit.ub.edu:2445/200227
publishDate 2023
publishDateSort 2023
reponame_str Dipòsit Digital de la UB
spelling Alginate Hydrogel Formulation with Ketorolac for the Treatment of Pain Related Sialolithiasis Silva, Cristina Ramos Yacasi, Gladys Rosario Mallandrich Miret, Mireia Colom Codina, Helena Suñer Carbó, J. (Joaquim) Noelia Pérez-González Calpena Campmany, Ana Cristina Fernández Campos, Francisco Glàndules salivals Gels (Farmàcia) Desenvolupament de medicaments Salivary glands Gels (Pharmacy) Drug development Abstract: Sialolithiasis mainly affects the oral salivary glands due to the presence of small stones that obstruct the secretion of saliva. The treatment and control of pain and inflammation during the course of this pathology is essential to guarantee the patient's comfort. For this reason, a ketorolac calcium cross-linked alginate hydrogel was developed, and it was then applied in the area of the buccal cavity. The formulation was characterized (swelling and degradation profile, extrusion, extensibility, surface morphology, viscosity, and drug release). The drug release was studied ex vivo in static Franz cells and with a dynamic ex vivo method under artificial saliva continuous flow. The product exhibits adequate physicochemical properties considering the intended purpose, and the drug concentrations retained in the mucosa were high enough to deliver a therapeutic local concentration able to reduce the pain associated with the patient's conditions. The results confirmed the suitability of the formulation for application in the mouth. https://hdl.handle.net/2445/200227
spellingShingle Alginate Hydrogel Formulation with Ketorolac for the Treatment of Pain Related Sialolithiasis
Silva, Cristina
Glàndules salivals
Gels (Farmàcia)
Desenvolupament de medicaments
Salivary glands
Gels (Pharmacy)
Drug development
status_str publishedVersion
title Alginate Hydrogel Formulation with Ketorolac for the Treatment of Pain Related Sialolithiasis
title_full Alginate Hydrogel Formulation with Ketorolac for the Treatment of Pain Related Sialolithiasis
title_fullStr Alginate Hydrogel Formulation with Ketorolac for the Treatment of Pain Related Sialolithiasis
title_full_unstemmed Alginate Hydrogel Formulation with Ketorolac for the Treatment of Pain Related Sialolithiasis
title_short Alginate Hydrogel Formulation with Ketorolac for the Treatment of Pain Related Sialolithiasis
title_sort Alginate Hydrogel Formulation with Ketorolac for the Treatment of Pain Related Sialolithiasis
topic Glàndules salivals
Gels (Farmàcia)
Desenvolupament de medicaments
Salivary glands
Gels (Pharmacy)
Drug development
topic_facet Glàndules salivals
Gels (Farmàcia)
Desenvolupament de medicaments
Salivary glands
Gels (Pharmacy)
Drug development
url https://hdl.handle.net/2445/200227